Following a recent poll, the VMD has refreshed the information provided in the monthly medicines update, please send any comments or feedback to postmaster@vmd.gov.uk.
New marketing authorisations:
See the VMD’s Product Information Database for more information.
The authorisation territories, GB or NI, are links to their entry in the VMD’s Product Information Database.
There may be a delay between the issuing of a Marketing Authorisation and the product being placed on the market.
|
New Marketing Authorisations
|
|
Product name and target species
|
Active substance
|
Authorisation Holder, territory, and distribution category
|
Therapeutic group
|
|
Labiprofen 150 mg/ml solution for injection for cattle, pigs and horses
|
Ketoprofen
|
Labiana Life Sciences SA
Authorised in GB and NI: POM-V
|
Anti-Inflammatory
|
Changes to authorisations most relevant to vets:
See the VMD’s Product Information Database for more information.
The authorisation territories, GB or NI, are links to their entry in the VMD’s Product Information Database.
Changes to the Summary of Product Characteristics (SPC), labels and leaflets may change how the medicines should be used. There may be a delay between these changes being authorised to implementation on product literature. Unless you have been advised otherwise, the labelling instructions on the pack which is dispensed should be followed.
Contact the VMD at postmaster@vmd.gov.uk
Veterinary Medicines: Three Key Changes post-Brexit
1 - UK medicines are now authorised by territory
The Northern Ireland Protocol means that Northern Ireland remains subject to EU legislation. Therefore, to implement a dual regulatory system, products are now authorised separately in Great Britain and Northern Ireland.
The VMD’s Product Information Database now shows the territory products are authorised as ‘Great Britain’, ‘Northern Ireland’ or ‘United Kingdom’ for products authorised through national only procedures prior to January 2021.
Marketing Authorisation numbers will continue to be prefixed with the letters ‘Vm’ and configured using the 5-digit company number followed by the 4-digit product number. Authorisation numbers for human medicines are prefixed with ‘PL’.
To be able to identify where products are authorised using the Vm number, the first number of the product number element will be used as a territory identification number. These are:
•4 – example 01234/4321: authorised across the UK
•5 – example 01234/5021: authorised in Great Britain only
•3 – example 01234/3021: authorised in Northern Ireland only
Products centrally authorised by the EU are also valid in Northern Ireland and will continue to display the EU authorisation number. Product labels may display more than one authorisation number if they are authorised across multiple territories.
2 - Using the cascade in Great Britain or Northern Ireland
There are changes to the order of cascade steps vets should follow.
Vets in Great Britain
You must look to use products authorised in the UK in the first instance. If there is a product authorised in Northern Ireland but not in Great Britain or UK wide, you will need to apply for a Special Import Certificate to legally obtain it for use under the cascade.
Vets in Northern Ireland
Because of the Northern Ireland Protocol, vets in Northern Ireland must consider Great Britain as a third country. Preferential consideration must be given to veterinary medicines authorised in the EU over those products only authorised in Great Britain.
If there is a product authorised in Great Britain but not in Northern Ireland or UK wide, you will need to apply for a Special Import Certificate to legally obtain it for use under the cascade.
Further information
New Guidance for prescribing vets on the use of the cascade is available on GOV.UK.
3 - Product Information Database
The VMD has launched a new streamlined Product Information Database (PID). The number of columns in the search results has been reduced to make it easier to use on mobile devices. By clicking the product name, you will be taken to the ‘Product Details’ page that contains more information and links to associated documents, such as the Summary of Product Characteristics.
Products are authorised separately in Great Britain and Northern Ireland and those that are authorised in both territories are given a separate entry in the PID. Products held by the same authorisation holder for the same product but authorised in more than one territory are linked under ‘Aligned Products’.